U.S. Markets close in 3 hrs 24 mins

Depomed, Inc. (DEPO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.555+0.255 (+4.048%)
As of 12:35PM EDT. Market open.
People also watch
Full screen
Previous Close6.300
Bid6.520 x 1200
Ask6.530 x 600
Day's Range6.160 - 6.575
52 Week Range5.880 - 27.020
Avg. Volume1,788,357
Market Cap412.72M
PE Ratio (TTM)-4.26
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Depomed Inc.
    Markit2 days ago

    See what the IHS Markit Score report has to say about Depomed Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • Thomson Reuters StreetEvents5 days ago

    Edited Transcript of DEPO earnings conference call or presentation 7-Aug-17 8:30pm GMT

    Q2 2017 Depomed Inc Earnings Call

  • Depomed, Inc. – Value Analysis (NASDAQ:DEPO) : August 11, 2017
    Capital Cube7 days ago

    Depomed, Inc. – Value Analysis (NASDAQ:DEPO) : August 11, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Depomed, Inc. a score of 28. Our analysis is based on comparing Depomed, Inc. with the following peers – BioDelivery Sciences International, Inc., Ironwood Pharmaceuticals, Inc. Class A, Mallinckrodt Plc, Insys Therapeutics, Inc., Pfizer Inc., Cara Therapeutics Inc, Galena Biopharma, Inc., Merck & Co., Inc. and Johnson ... Read more (Read more...)